|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Enoxaparin#Drug Interactions]] |
| {{Enoxaparin}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Drug Interactions==
| |
| Whenever possible, agents which may enhance the risk of [[hemorrhage]] should be discontinued prior to initiation of Lovenox therapy. These agents include medications such as: [[anticoagulants]], platelet inhibitors including [[acetylsalicylic acid]], [[salicylates]], [[NSAIDs]] (including ketorolac tromethamine), [[dipyridamole]], or [[sulfinpyrazone]]. If co-administration is essential, conduct close clinical and laboratory monitoring<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = LOVENOX (ENOXAPARIN SODIUM) INJECTION [SANOFI-AVENTIS U.S. LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5017a927-2a24-4f27-89f9-27c805bf7d59 | publisher = | date = | accessdate = 6 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Antiplatelet drugs]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |